The Discounted Cash Flow (DCF) valuation of Regeneron Pharmaceuticals Inc (REGN) is 597.83 USD. With the latest stock price at 529.24 USD, the upside of Regeneron Pharmaceuticals Inc based on DCF is 13.0%.
Based on the latest price of 529.24 USD and our DCF valuation, Regeneron Pharmaceuticals Inc (REGN) is a buy. buying Regeneron stocks now will result in a potential gain of 13.0%.
| Range | Selected | |
| WACC / Discount Rate | 8.2% - 10.6% | 9.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 443.80 - 960.11 | 597.83 |
| Upside | -16.1% - 81.4% | 13.0% |